Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Clears First Bangladesh Rx Supplies From Beximco Site

This article was originally published in Scrip

Executive Summary

Beximco Pharmaceuticals Ltd. has received US FDA approval to manufacture the antihypertensive, carvedilol, at its Tongi site in Bangladesh – the first prescription drug to be made in that country for export to the US.


Related Content

Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio